BeOne Medicines (BEIGF) Exchange Rate Effect (2015 - 2026)

BeOne Medicines (BEIGF) has 12 years of Exchange Rate Effect data on file, last reported at $19.3 million in Q1 2026.

• Exchange Rate Effect for Q1 2026 came in at $19.3 million, up 455.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $75.9 million (up 394.19% YoY), and the FY2025 annual result was $60.0 million, up 216.09% from the prior year.
• Exchange Rate Effect declined to $19.3 million in Q1 2026 per BEIGF's latest filing, from $23.2 million in the prior quarter.
• Over five years, Exchange Rate Effect peaked at $64.5 million in Q4 2022 and troughed at -$80.2 million in Q2 2022.
• A 5-year average of -$2.9 million and a median of $9.0 million in 2022 frame the typical range for Exchange Rate Effect.
• The sharpest annual moves came in 2022 and 2024: Exchange Rate Effect plunged 4247.95% in 2022, then jumped 5299.62% in 2024.
• A 5-year view of Exchange Rate Effect shows it stood at $64.5 million in 2022, then sank by 34.52% to $42.3 million in 2023, then tumbled by 222.35% to -$51.7 million in 2024, then surged by 144.79% to $23.2 million in 2025, then dropped by 16.59% to $19.3 million in 2026.
• Business Quant data shows BEIGF's Exchange Rate Effect at $19.3 million in Q1 2026, $23.2 million in Q4 2025, and $9.9 million in Q3 2025.